TY - JOUR
T1 - The Usability of Intensive Imaging Surveillance After Esophagectomy in Patients with Esophageal Cancer
AU - Takeuchi, Masashi
AU - Kawakubo, Hirofumi
AU - Matsuda, Satoru
AU - Fukuda, Kazumasa
AU - Nakamura, Rieko
AU - Kitagawa, Yuko
N1 - Funding Information:
The authors thank Kumiko Motooka, a staff member at the Department of Surgery in Keio University School of Medicine, for her help with the preparation of this manuscript.
Publisher Copyright:
© 2022, Society of Surgical Oncology.
PY - 2023/4
Y1 - 2023/4
N2 - Background: Although imaging surveillance after esophagectomy is required to achieve long-term survival for patients with esophageal cancer, the optimal surveillance timing and interval remain unclear. This study was designed to investigate the differences in oncological outcomes based on the detection method for recurrence and surveillance interval in patients with recurrence detected by routine imaging examination after esophagectomy. Methods: A total of 527 patients who underwent thoracic esophagectomy for esophageal cancer with R0 resection between 2003 and 2021 in our department were enrolled in this study. Postoperative, routine surveillance was conducted at an outpatient clinic every 3 months, thoracoabdominal computed tomography (CT) every 4–6 months, and esophagogastroduodenoscopy every 6 months. The detection method and optimal interval of imaging surveillance also were investigated. Results: Of all patients, 161 patients developed recurrence during surveillance; 110 (68.3 %) by routine surveillance and 37 (23.0%) not detected by routine surveillance. Among patients who were diagnosed with recurrence following routine surveillance, patients with pStage IV disease on imaging surveillance by thoracoabdominal CT at an interval of ≤ 5 months had a better survival rate than those with an interval of 6 months (P = 0.004), whereas no significant difference among different intervals was observed in patients with pStage I–III disease. Conclusions: Recurrence may have been detectable by our routine surveillance in approximately 70% of patients who developed recurrence. These findings demonstrate the necessity of different imaging surveillance intervals for different pStages of esophageal cancer.
AB - Background: Although imaging surveillance after esophagectomy is required to achieve long-term survival for patients with esophageal cancer, the optimal surveillance timing and interval remain unclear. This study was designed to investigate the differences in oncological outcomes based on the detection method for recurrence and surveillance interval in patients with recurrence detected by routine imaging examination after esophagectomy. Methods: A total of 527 patients who underwent thoracic esophagectomy for esophageal cancer with R0 resection between 2003 and 2021 in our department were enrolled in this study. Postoperative, routine surveillance was conducted at an outpatient clinic every 3 months, thoracoabdominal computed tomography (CT) every 4–6 months, and esophagogastroduodenoscopy every 6 months. The detection method and optimal interval of imaging surveillance also were investigated. Results: Of all patients, 161 patients developed recurrence during surveillance; 110 (68.3 %) by routine surveillance and 37 (23.0%) not detected by routine surveillance. Among patients who were diagnosed with recurrence following routine surveillance, patients with pStage IV disease on imaging surveillance by thoracoabdominal CT at an interval of ≤ 5 months had a better survival rate than those with an interval of 6 months (P = 0.004), whereas no significant difference among different intervals was observed in patients with pStage I–III disease. Conclusions: Recurrence may have been detectable by our routine surveillance in approximately 70% of patients who developed recurrence. These findings demonstrate the necessity of different imaging surveillance intervals for different pStages of esophageal cancer.
UR - http://www.scopus.com/inward/record.url?scp=85141861040&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141861040&partnerID=8YFLogxK
U2 - 10.1245/s10434-022-12739-y
DO - 10.1245/s10434-022-12739-y
M3 - Article
C2 - 36454376
AN - SCOPUS:85141861040
SN - 1068-9265
VL - 30
SP - 2190
EP - 2197
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 4
ER -